Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calcagno

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Behavioural Brain Research|November 20, 2019
Prolonged isolation stress accelerates the onset of Alzheimer's disease-related pathology in 5xFAD mice despite running wheels and environmental enrichmentJ L Peterman, J D White, A Calcagno, et al.
Journal of Neurovirology|January 19, 2022
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disordersA Barco, S Orlando, G Stroffolini, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
Infection|May 20, 2015
Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Muss, et al.
Infection|June 25, 2015
Erratum to: Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Mussi, et al.
Current HIV Research|August 10, 2014
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patientsS Bonora, A Calcagno, O Vigano, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal functionA Calcagno, D Gonzalez de Requena, M Simiele, et al.
BMC Geriatrics|April 22, 2018
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 yearsG Guaraldi, A Malagoli, A Calcagno, et al.
HIV Medicine|June 5, 2018
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre studyE Focà, G Cavaglià, S Rusconi, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIVA Borghetti, A Calcagno, F Lombardi, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Behavioural Brain Research|November 20, 2019
Prolonged isolation stress accelerates the onset of Alzheimer's disease-related pathology in 5xFAD mice despite running wheels and environmental enrichmentJ L Peterman, J D White, A Calcagno, et al.
Journal of Neurovirology|January 19, 2022
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disordersA Barco, S Orlando, G Stroffolini, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
Infection|May 20, 2015
Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Muss, et al.
Infection|June 25, 2015
Erratum to: Ageing with HIV: a multidisciplinary reviewA Calcagno, S Nozza, C Mussi, et al.
Current HIV Research|August 10, 2014
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patientsS Bonora, A Calcagno, O Vigano, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2013
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal functionA Calcagno, D Gonzalez de Requena, M Simiele, et al.
BMC Geriatrics|April 22, 2018
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 yearsG Guaraldi, A Malagoli, A Calcagno, et al.
HIV Medicine|June 5, 2018
Survival in HIV-infected patients with lymphoma according to the choice of antiretroviral treatment: an observational multicentre studyE Focà, G Cavaglià, S Rusconi, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2018
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIVA Borghetti, A Calcagno, F Lombardi, et al.
Pageof 10